Form 10-12B - Registration of securities [Section 12(b)]:
SEC Accession No. 0001493152-18-008376
Filing Date
2018-06-08
Accepted
2018-06-08 06:05:21
Documents
19

Document Format Files

Seq Description Document Type Size
1 form10-12b.htm 10-12B 75616
2 ex3-1.htm EX-3.1 16388
3 ex3-2.htm EX-3.2 121804
4 ex10-17.htm EX-10.17 70098
5 ex21-1.htm EX-21.1 3764
6 ex99-1.htm EX-99.1 2972453
7 ex99_01.jpg GRAPHIC 11008
8 ex99_02.jpg GRAPHIC 282779
9 ex99_03.jpg GRAPHIC 105027
10 image_001.jpg GRAPHIC 211285
11 image_002.jpg GRAPHIC 282779
12 image_003.jpg GRAPHIC 288847
13 image_004.jpg GRAPHIC 290294
14 image_005.jpg GRAPHIC 332953
15 image_006.jpg GRAPHIC 165700
16 image_007.jpg GRAPHIC 293174
17 image_008.jpg GRAPHIC 556613
18 image_009.jpg GRAPHIC 339023
19 image_010.jpg GRAPHIC 6628
  Complete submission text file 0001493152-18-008376.txt   7621609
Mailing Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501
Business Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501 510-521-3390
AgeX Therapeutics, Inc. (Filer) CIK: 0001708599 (see all company filings)

EIN.: 821436829 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-12B | Act: 34 | File No.: 001-38519 | Film No.: 18888016